Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from MaxCyte ( (MXCT) ).
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings due to an acquisition or disposal of voting rights. BlackRock, Inc. has crossed the threshold of voting rights, now holding a total of 7.62% in MaxCyte, Inc., which indicates a slight adjustment from its previous position. This change in voting rights could potentially impact MaxCyte’s governance and strategic decisions, with BlackRock’s increased stake possibly influencing future company directions.
More about MaxCyte
YTD Price Performance: 18.21%
Average Trading Volume: 57,462
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £409.6M
Learn more about MXCT stock on TipRanks’ Stock Analysis page.